We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$120B
AUM Growth
+$1.51B
Cap. Flow
-$3.03B
Cap. Flow %
-2.53%
Top 10 Hldgs %
14.33%
Holding
3,102
New
125
Increased
894
Reduced
1,362
Closed
90

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$529M
2
RTX icon
RTX Corp
RTX
+$496M
3
CVS icon
CVS Health
CVS
+$406M
4
USB icon
US Bancorp
USB
+$395M
5
TWX
Time Warner Inc
TWX
+$279M

Sector Composition

Rank Sector Weight
1 Financials 16.51%
2 Technology 14.95%
3 Healthcare 13.16%
4 Industrials 10.42%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEP icon
2726
Korea Electric Power
KEP
$15.5B
$306K ﹤0.01%
16,555
+1,670
+11% +$34.8K
SGMO
2727
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$306K ﹤0.01%
100,441
+9,100
+10% +$33.1K
MMI icon
2728
Marcus & Millichap
MMI
$1.18B
$305K ﹤0.01%
11,400
-4,800
-30% -$125K
BHBK
2729
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$302K ﹤0.01%
16,100
+1,200
+8% +$20K
EGIO
2730
DELISTED
Edgio, Inc. Common Stock
EGIO
$301K ﹤0.01%
2,990
CEMP
2731
DELISTED
Cempra, Inc.
CEMP
$300K ﹤0.01%
107,200
+38,300
+56% +$465K
ATRA icon
2732
Atara Biotherapeutics
ATRA
$73.6M
$299K ﹤0.01%
842
LAB icon
2733
Standard BioTools
LAB
$351M
$298K ﹤0.01%
41,000
-630
-2% -$3.96K
PACB icon
2734
Pacific Biosciences
PACB
$460M
$298K ﹤0.01%
78,500
-7,300
-9% -$53K
AAIC
2735
DELISTED
Arlington Asset Investment Corp.
AAIC
$298K ﹤0.01%
20,100
PFF icon
2736
iShares Preferred and Income Securities ETF
PFF
$13.3B
$297K ﹤0.01%
7,980
+547
+7% +$20.8K
PTHN
2737
DELISTED
Patheon N.V.
PTHN
$297K ﹤0.01%
+10,349
New +$286K
OKSB
2738
DELISTED
Southwest Bancorp Inc/OK
OKSB
$297K ﹤0.01%
10,257
WAYN
2739
DELISTED
Wayne Savings Bancshares Inc
WAYN
$296K ﹤0.01%
17,915
-59,999
-77% -$897K
NTRA icon
2740
Natera
NTRA
$38.6B
$295K ﹤0.01%
25,200
FNLC icon
2741
First Bancorp
FNLC
$394M
$294K ﹤0.01%
8,879
+200
+2% +$5.39K
WHG icon
2742
Westwood Holdings Group
WHG
$182M
$292K ﹤0.01%
4,861
SYUT
2743
DELISTED
Synutra International, Inc.
SYUT
$292K ﹤0.01%
54,493
-9,200
-14% -$44.3K
MCRN
2744
DELISTED
Milacron Holdings Corp.
MCRN
$291K ﹤0.01%
15,600
-2,500
-14% -$40.8K
NEO icon
2745
NeoGenomics
NEO
$2.04B
$290K ﹤0.01%
33,800
ARA
2746
DELISTED
American Renal Associates Holdings, Inc
ARA
$287K ﹤0.01%
13,500
ASCMA
2747
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$287K ﹤0.01%
17,631
LE icon
2748
Lands' End
LE
$369M
$285K ﹤0.01%
18,800
-1,400
-7% -$22.9K
AMNB
2749
DELISTED
American National Bankshares Inc
AMNB
$285K ﹤0.01%
8,200
+200
+3% +$6.1K
NXRT
2750
NexPoint Residential Trust
NXRT
$677M
$284K ﹤0.01%
12,700
+2,380
+23% +$46.7K

Similar funds

AllianceBernstein's Q4 2016 Portfolio in Review

As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
  • AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
  • AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
  • AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
  • AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
  • AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
  • AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.

Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.